Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events
Clinical trial NCT01770210 · COMPLETED
Trial details
- NCT number
- NCT01770210
- Sponsor
- Elpen Pharmaceutical Co. Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-02-01
- Primary completion
- 2014-07-01
- Enrollment
- 670
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.